Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ranjit Sah and Kuldeep Dhama.
Ranjit Sah
Connection Strength
3.351
Kuldeep Dhama
  1. Immunopathogenesis and immunobiology of SARS-CoV-2. Infez Med. 2021 Jun 01; 29(2):167-180.
    View in: PubMed
    Score: 0.237
  2. Community Behavioral and Perceived Responses in the COVID-19 Outbreak in Afghanistan: A Cross-Sectional Study. Disaster Med Public Health Prep. 2021 May 05; 1-7.
    View in: PubMed
    Score: 0.236
  3. COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic. Travel Med Infect Dis. 2021 May-Jun; 41:102037.
    View in: PubMed
    Score: 0.234
  4. Immunotherapies and immunomodulatory approaches in clinical trials - a mini review. Hum Vaccin Immunother. 2021 07 03; 17(7):1897-1909.
    View in: PubMed
    Score: 0.232
  5. AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021 Mar-Apr; 40:101989.
    View in: PubMed
    Score: 0.232
  6. Impact of COVID-19 on tourism in Nepal. J Travel Med. 2020 09 26; 27(6).
    View in: PubMed
    Score: 0.226
  7. SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med Infect Dis. 2020 Sep - Oct; 37:101830.
    View in: PubMed
    Score: 0.224
  8. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum Vaccin Immunother. 2020 12 01; 16(12):2891-2904.
    View in: PubMed
    Score: 0.223
  9. Is Sexual Route a Matter of Concern for the SARS-CoV-2/COVID-19? Arch Med Res. 2020 10; 51(7):745-746.
    View in: PubMed
    Score: 0.222
  10. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis. 2020 Sep - Oct; 37:101755.
    View in: PubMed
    Score: 0.221
  11. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications. Inflamm Res. 2021 Aug; 70(8):877-889.
    View in: PubMed
    Score: 0.059
  12. MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. Ann Clin Microbiol Antimicrob. 2021 Jan 18; 20(1):8.
    View in: PubMed
    Score: 0.058
  13. Bell's palsy as a possible neurological complication of COVID-19: A case report. Clin Case Rep. 2021 Feb; 9(2):747-750.
    View in: PubMed
    Score: 0.057
  14. After SARS-CoV-2, will H5N6 and other influenza viruses follow the pandemic path? Infez Med. 2020 Dec 01; 28(4):475-485.
    View in: PubMed
    Score: 0.057
  15. COVID-19: animals, veterinary and zoonotic links. Vet Q. 2020 Dec; 40(1):169-182.
    View in: PubMed
    Score: 0.057
  16. Recent advances in vaccine and immunotherapy for COVID-19. Hum Vaccin Immunother. 2020 12 01; 16(12):3011-3022.
    View in: PubMed
    Score: 0.057
  17. Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19. Curr Trop Med Rep. 2020 Sep 24; 1-7.
    View in: PubMed
    Score: 0.057
  18. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020 Sep 02; 19(1):40.
    View in: PubMed
    Score: 0.056
  19. Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps. Ann Clin Microbiol Antimicrob. 2020 07 18; 19(1):30.
    View in: PubMed
    Score: 0.056
  20. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens. 2020 06 28; 9(7).
    View in: PubMed
    Score: 0.056
  21. Mapping the Changes on Incidence, Case Fatality Rates and Recovery Proportion of COVID-19 in Afghanistan Using Geographical Information Systems. Arch Med Res. 2020 08; 51(6):600-602.
    View in: PubMed
    Score: 0.055
  22. MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies. Infez Med. 2020 Jun 01; 28(suppl 1):71-83.
    View in: PubMed
    Score: 0.055
  23. A vaccine is not too far for COVID-19. J Infect Dev Ctries. 2020 May 31; 14(5):450-453.
    View in: PubMed
    Score: 0.055
  24. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clin Microbiol Antimicrob. 2020 05 30; 19(1):23.
    View in: PubMed
    Score: 0.055
  25. Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools. Arch Med Res. 2020 07; 51(5):450-452.
    View in: PubMed
    Score: 0.055
  26. Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers. Travel Med Infect Dis. 2020 Mar - Apr; 34:101630.
    View in: PubMed
    Score: 0.054
  27. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr; 34:101623.
    View in: PubMed
    Score: 0.054
  28. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020 Ahead of print Jun 1; 28(2):139-142.
    View in: PubMed
    Score: 0.054
  29. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview Infez Med. 2020 Ahead Of Print Jun 1; 28(2):174-184.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.